Oncolytics Biotech Inc
TSX:ONC

Watchlist Manager
Oncolytics Biotech Inc Logo
Oncolytics Biotech Inc
TSX:ONC
Watchlist
Price: 1.73 CAD -2.81% Market Closed
Market Cap: 153.7m CAD

Wall Street
Price Targets

ONC Price Targets Summary
Oncolytics Biotech Inc

Wall Street analysts forecast ONC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONC is 4.67 CAD with a low forecast of 3.54 CAD and a high forecast of 5.51 CAD.

Lowest
Price Target
3.54 CAD
104% Upside
Average
Price Target
4.67 CAD
170% Upside
Highest
Price Target
5.51 CAD
219% Upside
Oncolytics Biotech Inc Competitors:
Price Targets
MRUS
Merus NV
47% Upside
ACAD
ACADIA Pharmaceuticals Inc
28% Upside
TH
Theratechnologies Inc
31% Upside
BVXP
Bioventix PLC
68% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
38% Upside
096530
Seegene Inc
40% Upside
ELDN
Eledon Pharmaceuticals Inc
148% Upside
STOK
Stoke Therapeutics Inc
73% Upside

Revenue
Forecast

Revenue Estimate
Oncolytics Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Oncolytics Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Oncolytics Biotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-49%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONC's stock price target?
Price Target
4.67 CAD

According to Wall Street analysts, the average 1-year price target for ONC is 4.67 CAD with a low forecast of 3.54 CAD and a high forecast of 5.51 CAD.

Back to Top